Adial Pharmaceuticals

AZRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.215 M

$3.89 +2.10%

Close of 3 Nov 2026

As of 3 Nov 2026, Adial Pharmaceuticals (AZR) has a market capitalization of $10.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.98T

Loss-making

Shares outstanding

2,625,890

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Adial Pharmaceuticals lists more than one class of stock. Company figures above cover all classes combined.

ADIL

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#415Aspire-LakewoodASBP$10.2M
#416Phio PharmaceuticalsPHIO$10.2M
#417Adial PharmaceuticalsAZR$10.2M
#418BioLineRxBLRX$9.76M
#419CalciMedicaCALC$9.56M

What if Adial Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $27.4T

$10,416,314

Per share 2,677,716× higher

Bitcoin $1.54T

$585,862.75

Per share 150,607× higher

Apple $4.94T

$1,880,316

Per share 483,372× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Adial Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.